| PDB0306 | Incidence of HCV reinfection among HIV-positive MSM and its association with sexual risk behavior: A longitudinal analysis | Poster exhibition | B12 |
| PDB0402 | HIV-1 DNA testing in viremic patients demonstrates a greater ability to detect drug resistance compared to plasma virus testing | Poster exhibition | B7 |
| PDB0403 | HIV-infected treatment-experienced children and adolescents from Sub-Saharan Africa: Clinical outcomes on third-line antiretroviral treatment in the New Horizons drug donation program | Poster exhibition | B51 |
| PDB0404 | Deep sequencing with unique molecular identifiers for evaluation of HIV-1 drug resistance in the DISCOVER pre-exposure prophylaxis trial | Poster exhibition | B7 |
| PDB0405 | Pretreatment low-frequency HIV drug resistance mutations in antiretroviral naive individuals in Botswana | Poster exhibition | B7 |
| PDB0406 | Doravirine resistance profile in clinical isolates and impact of baseline NNRTI resistance-associated mutations observed in treatment-naïve participants from phase 3 clinical trials | Poster exhibition | B35 |
| PDB0407 | Surveillance of transmitted HIV drug resistance among treatment-naïve children under 18 months in Brazil (2009-2018) | Poster exhibition | B7 |
| PDC0102 | High PrEP adherence in men who have sex with men and transgender women cohort in Manila, Philippines: Evidence of HIV protective levels from tenofovir blood concentrations in project PrEPPY | Poster exhibition | C47 |
| PDC0103 | Adherence to daily and event-driven pre-exposure prophylaxis among men who have sex with men in Taiwan | Poster exhibition | C47 |
| PDC0104 | Project My PrEP: Results from a PrEP demonstration project among high risk men who have sex with men (MSM) in Kuala Lumpur, Malaysia | Poster exhibition | C35 |